Thomas andresen

Thomas andresen

Company: T-Cypher Bio

Job title: ceo

Seminars:

Panel: Unveiling Distinctions: Evaluating TCR-T Cell Therapies, CAR-T, TCR Bispecifics, & Antibody Mimetics for Tailored Therapeutic Advancements 4:05 pm

• Quantifying Effectiveness: Comparing the relative affinities, potencies, and safety profiles of T-cell therapies, CAR-T, TCR bispecifics and antibody mimetics to discern their unique therapeutic characteristics • Strategic Suitability: Assessing the optimal indications and patient populations where each TCR modality excels • Beyond the Horizon: Exploring potential future modalities in the TCR therapy landscape, envisioning…Read more

day: Conference Day One

Revolutionizing TCR Therapy: Novel Technologies, Platforms, & Machine Learning in Target & TCR Discovery 12:05 pm

• The latest advancements in novel technologies facilitating the identification of precise targets in TCR therapy, pushing the boundaries of target and TCR discovery • Application of computational and machine learning tools, revolutionizing the analysis of complex biological data to uncover hidden patterns and accelerate target identification • Novel technologies and computational modelling is reshaping…Read more

day: Conference Day One

Panel: Unveiling Distinctions: Evaluating TCR-T Cell Therapies, CAR-T, TCR Bispecifics, & Antibody Mimetics for Tailored Therapeutic Advancements 3:00 pm

Quantifying Effectiveness: Comparing the relative affinities, potencies, and safety profiles of T-cell therapies, CAR-T, TCR bispecifics and antibody mimetics to discern their unique therapeutic characteristics Strategic Suitability: Assessing the optimal indications and patient populations where each TCR modality excels Beyond the Horizon: Exploring potential future modalities in the TCR therapy landscape, envisioning the untapped possibilities…Read more

day: DAY ONE TRACK 3 A

Revolutionizing TCR Therapy: Novel Technologies, Platforms, & Machine Learning in Target & TCR Discovery 2:00 pm

The latest advancements in novel technologies facilitating the identification of precise targets in TCR therapy, pushing the boundaries of target and TCR discovery Application of computational and machine learning tools, revolutionizing the analysis of complex biological data to uncover hidden patterns and accelerate target identification Novel technologies and computational modelling is reshaping the landscape of…Read more

day: DAY ONE TRACK 2 A

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.